Amarin (AMRN) Revenue & Revenue Breakdown
Amarin Revenue Highlights
Latest Revenue (Y)
$285.30M
Latest Revenue (Q)
$41.85M
Main Segment (Y)
Product
Amarin Revenue by Period
Amarin Revenue by Year
Date | Revenue | Change |
---|---|---|
2023-12-31 | $285.30M | -22.72% |
2022-12-31 | $369.19M | -36.69% |
2021-12-31 | $583.19M | -5.03% |
2020-12-31 | $614.06M | 42.89% |
2019-12-31 | $429.75M | 87.49% |
2018-12-31 | $229.21M | 26.56% |
2017-12-31 | $181.10M | 39.22% |
2016-12-31 | $130.08M | 59.11% |
2015-12-31 | $81.76M | 50.84% |
2014-12-31 | $54.20M | 105.69% |
2013-12-31 | $26.35M | 100.00% |
2012-12-31 | - | 100.00% |
2011-12-31 | - | 100.00% |
2010-12-31 | - | 100.00% |
2009-12-31 | - | 100.00% |
2008-12-31 | - | -100.00% |
2007-12-31 | $7.37M | 1373.00% |
2006-12-31 | $500.00K | - |
2005-12-31 | $500.00K | -50.84% |
2004-12-31 | $1.02M | -86.19% |
2003-12-31 | $7.37M | -88.76% |
2002-12-31 | $65.51M | 21.82% |
2001-12-31 | $53.77M | 206.36% |
2000-12-31 | $17.55M | 56.46% |
1999-12-31 | $11.22M | -40.96% |
1998-08-31 | $19.00M | -21.81% |
1997-08-31 | $24.30M | 13.02% |
1996-08-31 | $21.50M | -26.12% |
1995-08-31 | $29.10M | 55.61% |
1994-08-31 | $18.70M | 27.21% |
1993-08-31 | $14.70M | - |
Amarin Revenue by Quarter
Date | Revenue | Change |
---|---|---|
2024-09-30 | $41.85M | -38.06% |
2024-06-30 | $67.57M | 19.62% |
2024-03-31 | $56.49M | -25.05% |
2023-12-31 | $75.36M | 14.09% |
2023-09-30 | $66.06M | -17.60% |
2023-06-30 | $80.17M | -6.76% |
2023-03-31 | $85.97M | -4.73% |
2022-12-31 | $90.25M | 0.41% |
2022-09-30 | $89.88M | -4.83% |
2022-06-30 | $94.44M | -0.20% |
2022-03-31 | $94.63M | -34.51% |
2021-12-31 | $144.49M | 1.73% |
2021-09-30 | $142.04M | -8.06% |
2021-06-30 | $154.49M | 8.66% |
2021-03-31 | $142.17M | -15.00% |
2020-12-31 | $167.25M | 6.87% |
2020-09-30 | $156.50M | 15.65% |
2020-06-30 | $135.32M | -12.69% |
2020-03-31 | $154.99M | 8.18% |
2019-12-31 | $143.28M | 27.46% |
2019-09-30 | $112.41M | 11.52% |
2019-06-30 | $100.79M | 37.55% |
2019-03-31 | $73.28M | -5.24% |
2018-12-31 | $77.33M | 39.78% |
2018-09-30 | $55.32M | 5.09% |
2018-06-30 | $52.64M | 19.86% |
2018-03-31 | $43.92M | -18.47% |
2017-12-31 | $53.87M | 13.74% |
2017-09-30 | $47.36M | 4.68% |
2017-06-30 | $45.24M | 30.61% |
2017-03-31 | $34.64M | -10.49% |
2016-12-31 | $38.70M | 18.21% |
2016-09-30 | $32.73M | -1.14% |
2016-06-30 | $33.11M | 29.63% |
2016-03-31 | $25.54M | -4.09% |
2015-12-31 | $26.63M | 23.97% |
2015-09-30 | $21.48M | 21.32% |
2015-06-30 | $17.71M | 11.13% |
2015-03-31 | $15.93M | -3.32% |
2014-12-31 | $16.48M | 16.47% |
2014-09-30 | $14.15M | 12.24% |
2014-06-30 | $12.61M | 14.94% |
2014-03-31 | $10.97M | 8.52% |
2013-12-31 | $10.11M | 20.27% |
2013-09-30 | $8.40M | 52.78% |
2013-06-30 | $5.50M | 134.94% |
2013-03-31 | $2.34M | 100.00% |
2012-12-31 | - | 100.00% |
2012-09-30 | - | 100.00% |
2012-06-30 | - | 100.00% |
2012-03-31 | - | 100.00% |
2011-12-31 | - | 100.00% |
2011-09-30 | - | 100.00% |
2011-06-30 | - | 100.00% |
2011-03-31 | - | 100.00% |
2010-12-31 | - | 100.00% |
2010-09-30 | - | 100.00% |
2010-06-30 | - | 100.00% |
2010-03-31 | - | 100.00% |
2009-06-30 | - | 100.00% |
2008-06-30 | - | 100.00% |
2008-03-31 | - | 100.00% |
2007-12-31 | - | 100.00% |
2007-09-30 | - | 100.00% |
2007-06-30 | - | 100.00% |
2007-03-31 | - | -100.00% |
2006-12-31 | $400.00K | 300.00% |
2006-09-30 | $100.00K | - |
Amarin Revenue Breakdown
Amarin Revenue Breakdown by Product
Annual Revenue by Product
Product/Service | Dec 23 | Dec 22 | Dec 21 | Dec 20 | Dec 19 |
---|---|---|---|---|---|
Product | $285.30M | $366.51M | $580.32M | $607.02M | $427.39M |
Licensing And Royalty | $21.61M | $2.68M | $2.87M | $7.04M | - |
License | - | - | - | - | $2.36M |
Latest
Quarterly Revenue by Product
Product/Service | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Product | $41.85M | $47.51M | $55.16M | $70.56M | $64.90M | $65.19M | $84.65M | $89.51M | $89.22M | $93.80M | $93.99M | $143.72M | $141.44M | $153.77M | $141.38M | $165.91M | $155.19M | $133.72M | $152.20M | $142.04M |
Licensing And Royalty | $446.00K | $19.98M | $1.36M | $4.16M | $1.15M | $14.98M | $1.32M | $738.00K | $656.00K | $644.00K | $644.00K | $769.00K | $596.00K | $715.00K | $787.00K | $1.34M | $1.31M | $1.59M | $2.79M | - |
License | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $1.23M |
Latest
Amarin Peer Comparison by Revenue
Ticker | Company | Last Year Revenue | Last Quarter Revenue |
---|---|---|---|
JNJ | Johnson & Johnson | $85.15B | $22.47B |
MRK | Merck | $60.12B | $16.66B |
ABBV | AbbVie | $54.32B | $14.46B |
NVS | Novartis | $46.66B | $11.83B |
AZN | AstraZeneca | $45.81B | $12.68B |
BMY | Bristol-Myers Squibb Company | $45.01B | $11.89B |
SNY | Sanofi | $43.07B | $11.12B |
GSK | GSK | $30.33B | $7.36B |
AMGN | Amgen | $28.19B | $8.50B |
GILD | Gilead Sciences | $27.12B | $7.55B |
BIIB | Biogen | $9.84B | $2.47B |
AMRN | Amarin | $285.30M | $41.85M |